Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model

Klaus Mueller, Guido Henke, Sophie Pietschmann, Stefaan van Gool, Steven De Vleeschouwer, Andre O. von Bueren, Inge Compter, Carsten Friedrich, Christiane Matuschek, Gunther Klautke, Rolf-Dieter Kortmann, Thomas Hundsberger, Brigitta G. Baumert

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)325-332
JournalJournal of Neuro-Oncology
Volume124
Issue number2
DOIs
Publication statusPublished - Sep 2015

Keywords

  • Relapsed high-grade gliomas
  • Prognostic model
  • Re-irradiation
  • Dendritic cell vaccination
  • Recurrent glioblastoma
  • Salvage treatment
  • Prognosis

Cite this

Mueller, K., Henke, G., Pietschmann, S., van Gool, S., De Vleeschouwer, S., von Bueren, A. O., Compter, I., Friedrich, C., Matuschek, C., Klautke, G., Kortmann, R-D., Hundsberger, T., & Baumert, B. G. (2015). Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model. Journal of Neuro-Oncology, 124(2), 325-332. https://doi.org/10.1007/s11060-015-1844-8